Related Experiment Video

Updated: Jul 6, 2026

Utilization of the Soft Agar Colony Formation Assay to Identify Inhibitors of Tumorigenicity in Breast Cancer Cells
11:06

Utilization of the Soft Agar Colony Formation Assay to Identify Inhibitors of Tumorigenicity in Breast Cancer Cells

Published on: May 20, 2015

Agelastatin A: a novel inhibitor of osteopontin-mediated adhesion, invasion, and colony formation

Charlene K Mason1, Suzanne McFarlane, Patrick G Johnston

  • 1Centre for Cancer Research and Cell Biology, Queen's University Belfast, Northern Ireland, UK.

Molecular Cancer Therapeutics
|March 19, 2008
PubMed

Insights

(-)-Agelastatin A effectively inhibits osteopontin (OPN)-mediated cancer progression by down-regulating beta-catenin and up-regulating Tcf-4. This natural compound shows potent antitumor effects, inhibiting cell invasion and proliferation.

Area of Science:

  • Natural Products Chemistry
  • Cancer Biology
  • Molecular Oncology

Background:

  • Osteopontin (OPN) plays a crucial role in neoplastic transformation and metastasis.
  • Effective inhibitors of OPN-mediated malignant progression are needed.
  • (-)-Agelastatin A, a natural oroidin alkaloid, exhibits potent in vitro antitumor activity, often exceeding that of cisplatin.

Purpose of the Study:

  • To investigate the effects of (-)-Agelastatin A on OPN-mediated malignant transformation in mammary epithelial cells.
  • To elucidate the molecular mechanisms underlying (-)-Agelastatin A's anti-cancer properties.
  • To evaluate the impact of (-)-Agelastatin A on key cancer hallmarks like invasion and proliferation.

Main Methods:

  • Treatment of mammary epithelial cell lines (R37, C9, MDA-MB-231, MDA-MB-435s) with (-)-Agelastatin A.
  • Analysis of OPN, Tcf-4, and beta-catenin protein expression.
  • Assessment of anchorage-independent growth, adhesion, and invasion.
  • RNA interference (siRNA) to suppress Tcf-4 expression.
  • Cell cycle analysis to determine proliferation effects.

Main Results:

  • (-)-Agelastatin A inhibited OPN protein expression and reduced beta-catenin levels.
  • It enhanced the expression of the OPN inhibitor Tcf-4.
  • The compound reduced anchorage-independent growth, adhesion, and invasion in multiple cell lines.
  • Tcf-4 suppression induced malignant transformation, which was reversed by (-)-Agelastatin A.
  • (-)-Agelastatin A caused cell cycle arrest at the G2 phase, inhibiting proliferation.

Conclusions:

  • (-)-Agelastatin A effectively represses OPN-mediated malignant cell invasion, adhesion, and colony formation.
  • The mechanism involves simultaneous down-regulation of beta-catenin and up-regulation of Tcf-4.
  • This natural compound demonstrates significant potential as an anti-cancer agent by targeting key pathways in cancer progression.

More Related Videos

Quantitative Measurement of Invadopodia-mediated Extracellular Matrix Proteolysis in Single and Multicellular Contexts14:23

Quantitative Measurement of Invadopodia-mediated Extracellular Matrix Proteolysis in Single and Multicellular Contexts

Published on: August 27, 2012

Related Concept Videos

Activation of Integrins01:15

Activation of Integrins

Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Integrins01:10

Integrins

Animal and protozoan cells do not have cell walls to help maintain shape and provide structural stability. Instead, these eukaryotic cells secrete a sticky mass of carbohydrates and proteins into the spaces between adjacent cells. This network of proteins and molecules is called an extracellular matrix or ECM.
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...